ThromboGenics NV announced that its Board of Directors has nominated Emmanuele Attout to be its new Independent non-executive director. Mrs. Attout will join the Audit Committee of the company. Mrs. Attout has been an audit partner at PricewaterhouseCoopers since 1994.

She has been in charge of audits of a range of clients including banks, insurance companies, investment funds and assets managers. She has in recent years been in charge of the audits of listed pharmaceuticals companies and life sciences business out of which she brings substantial relevant experience to the Board and to the Audit Committee.